Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study

ID#: NCT05535660

Age: 18 - 45 years

Gender: Female

Healthy Subjects: Accepts Healthy Volunteers

Recruitment Status: Recruiting

Start Date: July 29, 2022

End Date: June 30, 2023

Contact Information:
Nico Tavella
212-241-3888
Summary:

The purpose of this study is to ascertain lipid profiles during pregnancy, specifically during the 24-28 week gestation and again near term at 36 weeks gestation. The research team are investigating whether lipid profiles can predict adverse maternal and neonatal outcomes.

Eligibility:



Inclusion Criteria:

- Singleton pregnancy

- Ages 18-45

- Presentation to prenatal care by the 2nd trimester

- Prenatal care at Mount Sinai Hospital

- Anticipated delivery at Mount Sinai Hospital

Exclusion Criteria:

- Multiple gestations

- Preexisting hyperlipidemia

- Preexisting diabetes

- Delayed presentation to prenatal care after the 2nd trimester

5. Prenatal care or delivery outside of Mount Sinai Health System

Find a Clinical Trial Find Cancer Clinical Trials